PubRank

Tsutomu Imaizumi

Author PubWeight™ 223.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002 7.11
2 The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009 5.24
3 The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014 4.83
4 Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006 3.43
5 Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002 3.20
6 Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 2004 2.89
7 Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2008 2.54
8 Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010 2.37
9 Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART). J Am Coll Cardiol 2002 2.26
10 Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 2005 2.06
11 Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging 2011 2.00
12 Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006 1.86
13 Apoptosis induced by inhibition of cyclic AMP response element-binding protein in vascular smooth muscle cells. Circulation 2003 1.81
14 Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003 1.79
15 Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med 2007 1.79
16 Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 2006 1.70
17 Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res 2007 1.70
18 Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008 1.70
19 Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 2002 1.70
20 Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2002 1.67
21 Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int 2012 1.62
22 Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004 1.61
23 Ultrasound stimulation restores impaired neovascularization-related capacities of human circulating angiogenic cells. Cardiovasc Res 2012 1.57
24 Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J Am Coll Cardiol 2004 1.56
25 Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial. J Hypertens 2014 1.56
26 Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease. Circ J 2007 1.55
27 Prediction of coronary artery disease in patients undergoing carotid endarterectomy. J Neurosurg 2005 1.55
28 Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol 2007 1.54
29 Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007 1.53
30 Systolic blood pressure predicts cardiovascular mortality in a farming but not in a fishing community. -A 40-year follow up of the Japanese cohorts of the seven countries study-. Circ J 2011 1.49
31 How to avoid development of AV block during RF ablation: anatomical and electrophysiological analyses at the time of AV node ablation. Pacing Clin Electrophysiol 2012 1.45
32 Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats. Circ J 2014 1.45
33 Comparison of gene expression profiling in pressure and volume overload-induced myocardial hypertrophies in rats. Hypertens Res 2006 1.45
34 Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res 2012 1.43
35 Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients. J Hypertens 2011 1.42
36 Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2004 1.39
37 National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002 1.36
38 Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 2006 1.30
39 Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 2004 1.29
40 Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism 2006 1.26
41 Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002 1.25
42 Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010 1.24
43 Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 2003 1.22
44 Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int 2007 1.21
45 Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev 2007 1.21
46 Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 2006 1.19
47 AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction. Kidney Int 2004 1.19
48 Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 2005 1.19
49 Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res 2005 1.19
50 Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med 2007 1.14
51 Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 2006 1.13
52 Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J Mol Cell Cardiol 2004 1.12
53 Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 2004 1.10
54 The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 2007 1.09
55 Plasma aldosterone levels and development of insulin resistance: prospective study in a general population. Hypertension 2011 1.08
56 Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 2005 1.08
57 Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. J Am Coll Cardiol 2005 1.07
58 Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 2005 1.07
59 Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes. Microvasc Res 2007 1.05
60 Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol 2005 1.05
61 Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res 2005 1.05
62 Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. Microvasc Res 2006 1.05
63 Dynamicity of the J-wave in idiopathic ventricular fibrillation with a special reference to pause-dependent augmentation of the J-wave. J Am Coll Cardiol 2012 1.04
64 Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther 2010 1.04
65 Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 2003 1.02
66 Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2003 1.02
67 Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2006 1.02
68 Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 2006 1.02
69 Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Metabolism 2009 1.01
70 Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc Res 2005 1.01
71 Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Pathol 2007 1.01
72 Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells. Hum Gene Ther 2003 1.00
73 Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension 2003 1.00
74 Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 2002 1.00
75 Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). J Am Geriatr Soc 2008 1.00
76 Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem Biophys Res Commun 2007 0.99
77 Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 2002 0.99
78 Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. Atherosclerosis 2011 0.99
79 Utility of measuring C-reactive protein for prediction of in-hospital events in patients with acute aortic dissection. Heart Vessels 2012 0.99
80 Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr Neurovasc Res 2006 0.98
81 Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling. Am J Pathol 2004 0.97
82 LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone. J Lipids 2011 0.97
83 Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression. FEBS Lett 2005 0.97
84 Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis 2006 0.97
85 Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Diabetes Metab Res Rev 2008 0.97
86 Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2012 0.97
87 Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species. Ophthalmic Res 2007 0.97
88 Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. PLoS One 2009 0.96
89 Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb 2011 0.96
90 Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc Res 2005 0.96
91 Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression. Microvasc Res 2007 0.95
92 Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients. Hypertens Res 2009 0.95
93 Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy. Diabetes Metab Res Rev 2009 0.95
94 Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats. Basic Res Cardiol 2009 0.94
95 Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med 2009 0.94
96 Implantation of pacemaker for sick sinus syndrome in a patient with persistent left superior vena cava and absent right superior vena cava. Heart Vessels 2008 0.94
97 Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J Gastroenterol 2012 0.93
98 Characteristics of electrocardiographic repolarization in acute myocardial infarction complicated by ventricular fibrillation. J Electrocardiol 2012 0.93
99 Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension 2009 0.93
100 Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis. J Cardiovasc Pharmacol 2003 0.92
101 Safety and efficacy of repeated sauna bathing in patients with chronic systolic heart failure: a preliminary report. J Card Fail 2005 0.92
102 Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography. Diabetes Care 2012 0.91
103 Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties. Microvasc Res 2006 0.91
104 Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension. Int J Cardiol 2008 0.91
105 Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Arterioscler Thromb Vasc Biol 2007 0.91
106 Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction. Am J Pathol 2011 0.91
107 Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes. Atherosclerosis 2007 0.91
108 Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications. Curr Drug Targets 2008 0.90
109 Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication. Curr Pharm Des 2008 0.90
110 Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol 2013 0.89
111 Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy. Hypertens Res 2004 0.89
112 Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects. Cardiovasc Ther 2011 0.89
113 Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 2003 0.89
114 Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 2003 0.89
115 Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. Cardiovasc Hematol Agents Med Chem 2007 0.88
116 Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography. Hypertens Res 2008 0.88
117 Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome. Heart Vessels 2011 0.87
118 Longest survivor of pulmonary atresia with ventricular septal defect: well-developed major aortopulmonary collateral arteries demonstrated by multidetector computed tomography. Circulation 2011 0.87
119 Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment. Hypertens Res 2008 0.86
120 Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging. JACC Cardiovasc Imaging 2013 0.86
121 Inhibition of intrinsic interferon-gamma function prevents neointima formation after balloon injury. Hypertension 2007 0.86
122 Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women. Hypertens Res 2011 0.86
123 Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. J Cardiovasc Pharmacol 2005 0.86
124 Tenascin-C is expressed in abdominal aortic aneurysm tissue with an active degradation process. Pathol Int 2011 0.85
125 Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy. Br J Ophthalmol 2007 0.85
126 Large blood pressure variability and hypertensive cardiac remodeling--role of cardiac inflammation. Circ J 2009 0.85
127 Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice. Brain Res 2007 0.85
128 Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies. Arterioscler Thromb Vasc Biol 2005 0.85
129 Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans. Clin Biochem 2012 0.85
130 Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease. Cardiovasc Ther 2008 0.84
131 Renal Nerve-Mediated Erythropoietin Release Confers Cardioprotection During Remote Ischemic Preconditioning. Circ J 2015 0.84
132 Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia. J Mol Cell Cardiol 2011 0.84
133 High-sensitive troponin T is associated with atrial fibrillation in a general population. Int J Cardiol 2012 0.84
134 Elevated circulating oxidized LDL levels in Japanese subjects with the metabolic syndrome. Int J Cardiol 2006 0.84
135 Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan. Int J Cardiol 2011 0.83
136 Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study. J Hypertens 2004 0.83
137 Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation. FEBS Lett 2006 0.83
138 Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Hypertens Res 2007 0.83
139 Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes. Arterioscler Thromb Vasc Biol 2007 0.83
140 High plasma level of remnant-like particle cholesterol in the metabolic syndrome. Diabetes Care 2005 0.83
141 Increased levels of pigment epithelium-derived factor in aqueous humor of patients with uveitis. Br J Ophthalmol 2006 0.83
142 Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol 2004 0.83
143 Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways. Hypertens Res 2010 0.83
144 Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus. J Clin Endocrinol Metab 2013 0.82
145 Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res 2007 0.82
146 Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10-year prospective study. Clin Endocrinol (Oxf) 2013 0.82
147 Plasma endothelin-1 level is a predictor of 10-year mortality in a general population: the Tanushimaru study. Circ J 2012 0.82
148 A case-control study found that low albumin and smoking were associated with aortic dissection. J Clin Epidemiol 2004 0.82
149 Inhibition of platelet adherence to mononuclear cells by alpha-tocopherol: role of P-selectin. Circulation 2004 0.82
150 Special report from the heart transplant candidate registry committee in Japan. J Heart Lung Transplant 2005 0.81
151 Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv 2012 0.81
152 Statin therapy resolves coronary artery inflammation. JACC Cardiovasc Imaging 2013 0.81
153 Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation. J Am Coll Cardiol 2003 0.81
154 Factors associated with plasma ghrelin level in Japanese general population. Clin Endocrinol (Oxf) 2011 0.81
155 Reduction and activation of circulating dendritic cells in patients with decompensated heart failure. Int J Cardiol 2009 0.81
156 Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population. J Epidemiol 2012 0.81
157 Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Hum Gene Ther 2004 0.81
158 Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 2013 0.81
159 Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis. Br J Ophthalmol 2006 0.81
160 Cardiovascular disease in diabetes. Mini Rev Med Chem 2006 0.81
161 Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare. Metabolism 2003 0.81
162 Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells. Am J Physiol Endocrinol Metab 2009 0.81
163 Impaired endothelium-dependent and -independent vasodilation in young female athletes with exercise-associated amenorrhea. Arterioscler Thromb Vasc Biol 2006 0.81
164 The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease. Clin Cardiol 2010 0.81
165 Pigment epithelium-derived factor (PEDF) prevents advanced glycation end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its anti-oxidative properties. Protein Pept Lett 2007 0.80
166 Coexistence of hypercholesterolemia and hypertension impairs adventitial vascularization. Hypertension 2002 0.80
167 Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue. Atherosclerosis 2011 0.80
168 Screening for Fabry disease in patients with left ventricular hypertrophy. Int J Cardiol 2012 0.80
169 Long-term results of the maze procedure on left ventricular function for persistent atrial fibrillation associated with mitral valve disease. Heart Vessels 2011 0.80
170 Pigment epithelium-derived factor (PEDF) blocks the interleukin-6 signaling to C-reactive protein expression in Hep3B cells by suppressing Rac-1 activation. Life Sci 2006 0.80
171 Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment. Europace 2008 0.79
172 Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans. Metabolism 2006 0.79
173 Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans. Clin Biochem 2012 0.79
174 Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population. Clin Cardiol 2009 0.79
175 Pheochromocytoma presenting as recurrent hypotension and syncope. Intern Med 2005 0.79
176 Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B. Microvasc Res 2005 0.79
177 Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: the SPECIAL Study. Atherosclerosis 2008 0.79
178 Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts. J Cardiovasc Pharmacol 2003 0.78
179 Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats. Circ J 2013 0.78
180 Early outgrowth EPCs generation is reduced in patients with Buerger's disease. Clin Res Cardiol 2010 0.78
181 Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value. Thromb Res 2007 0.78
182 [Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy]. Nippon Ganka Gakkai Zasshi 2005 0.78
183 Serum uric acid is associated with the left ventricular mass index in males of a general population. Int Heart J 2014 0.78
184 High serum N-acetyl-ß-d-glucosaminidase activity is a predictor of 28-year mortality in a population of community-dwelling Japanese-the Tanushimaru study. J Am Geriatr Soc 2013 0.78
185 Portable-type signal-averaged electrocardiography with dipyridamole to detect patients with coronary artery disease. Circ J 2006 0.78
186 Portable type signal-averaged electrocardiography with dipyridamole: a new and convenient method to detect patients with coronary artery disease and ischemia. Circ J 2005 0.78
187 High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population. Clin Cardiol 2011 0.77
188 Reduction in morning blood pressure is a key factor for ameliorating urinary albumin excretion in patients with morning hypertension irrespective of treatment regimen. Circ J 2013 0.77
189 Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation. Antioxid Redox Signal 2002 0.77
190 Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes. Rejuvenation Res 2013 0.77
191 Adiponectin is inversely associated with ratio of serum levels of AGEs to sRAGE and vascular inflammation. Int J Cardiol 2012 0.77
192 Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation. J Lipid Res 2002 0.77
193 Detection of coronary artery stenosis after successful percutaneous coronary intervention by dipyridamole stress portable type signal-averaged electrocardiography: a prospective study. Heart Vessels 2008 0.76
194 Molecular mechanism of aggravation of hypertensive organ damages by short-term blood pressure variability. Curr Hypertens Rev 2014 0.76
195 Persistent coronary arterial inflammation in a patient long after the onset of Kawasaki disease. Int J Cardiol 2011 0.76
196 HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats. J Cardiovasc Pharmacol 2005 0.76
197 Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice. Hypertens Res 2012 0.76
198 Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction. Int J Cardiol 2012 0.76
199 Low-density lipoprotein levels are one of the independent determinants of circulating levels of advanced glycation end products in nondiabetic subjects. Clin Cardiol 2009 0.76
200 Selective gene expression analysis of muscular and vascular components in hearts using laser microdissection method. Int J Vasc Med 2012 0.76
201 Correction: FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs. PLoS One 2015 0.75
202 Mobile left atrial round mass free floating in mitral regurgitation flow mimicking a whale spray. BMJ Case Rep 2014 0.75
203 Coexistence of impairment of endothelium-derived nitric oxide and platelet-derived nitric oxide in patients with coronary risk factors. Circ J 2002 0.75
204 Is low diastolic blood pressure an independent risk for cardiovascular events in patients with manifest atherosclerotic disease? Hypertension 2012 0.75
205 SOCS3: A novel therapeutic target for cardioprotection. JAKSTAT 2012 0.75
206 Characteristic features of QRST integral mapping in patients with high risk Brugada syndrome. Circ J 2007 0.75
207 [Diagnostic criteria for syndrome X]. Nihon Rinsho 2003 0.75
208 [Cardiac remodeling]. Nihon Rinsho 2007 0.75
209 High level of plasma endothelin-1 predicts development of hypertension in normotensive subjects. Am J Hypertens 2010 0.75
210 Pigment epithelium-derived factor (PEDF) inhibits angiotensin II-induced smooth muscle cell proliferation through its anti-oxidative properties. Protein Pept Lett 2007 0.75
211 [Gene therapy and cell therapy for idiopathic pulmonary arterial hypertension]. Nihon Rinsho 2008 0.75
212 [White coat hypertension]. Nihon Rinsho 2006 0.75
213 [Pheochromocytoma presenting as acute heart failure]. Nihon Naika Gakkai Zasshi 2002 0.75
214 High level of plasma remnant-like particle cholesterol may predispose to development of hypertension in normotensive subjects. Am J Hypertens 2013 0.75
215 [Protective effect of alpha beta-blockers on hypertensive target-organ damage]. Nihon Rinsho 2004 0.75
216 Stent-anchored coil embolotherapy--novel treatment procedure for huge pulmonary arterio-venous malformation in hereditary hemorrhagic telangiectasia. Int J Cardiol 2012 0.75
217 [Component of coronary artery disease]. Nihon Rinsho 2011 0.75
218 [Alpha beta-blockers for patients with hypertension]. Nihon Rinsho 2006 0.75
219 Asymmetrical dimethylarginine level is independently associated with circulating levels of RAGE and PEDF. Int J Cardiol 2012 0.75
220 [Renin-angiotensin system in congestive heart failure]. Nihon Rinsho 2005 0.75
221 [Therapy for hypertension associated with heart failure]. Nihon Naika Gakkai Zasshi 2003 0.75
222 [Not Available]. Clin Calcium 2003 0.75
223 [Pathophysiology of mild hypertension: role of endothelial function]. Nihon Rinsho 2008 0.75
224 "Lead tube"-like aorta with intractable systolic hypertension. Clin Cardiol 2005 0.75
225 Respiratory variation of vertebral arterial flow in a patient scheduled for coronary artery bypass graft surgery: lesson from atypical subclavian steal phenomenon. Circ J 2013 0.75
226 Autologous transplantation of bone marrow mononuclear cells improved ischemic peripheral neuropathy in humans. J Am Coll Cardiol 2010 0.75
227 [Calcium antagonists and ischemic heart disease]. Clin Calcium 2005 0.75
228 [Series: Clinical study from Japan and its reflections morning hypertension and angiotensin receptor blocker/hydrochlorothiazide combination therapy study--MAPPY study]. Nihon Naika Gakkai Zasshi 2012 0.75
229 New computer model for prediction of individual 10-year mortality on the basis of conventional atherosclerotic risk factors. Atherosclerosis 2013 0.75
230 Images in cardiology. Disappearance of cardiac gallium uptake after corticosteroid therapy for sarcoidosis. Clin Cardiol 2004 0.75
231 [Physiopathology and treatment of heart failure due to poor dilatation]. Nihon Naika Gakkai Zasshi 2003 0.75
232 The prostacyclin analog beraprost sodium augments the efficacy of therapeutic angiogenesis induced by autologous bone marrow cells. Ann Vasc Surg 2006 0.75
233 [Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors]. Nihon Rinsho 2005 0.75
234 P wave signal-averaged electrocardiography predicts recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome who underwent successful catheter ablation: a prospective study. J Cardiovasc Electrophysiol 2002 0.75
235 Vitamin C reversed malfunction of peripheral blood-derived mononuclear cells in smokers through antioxidant properties. Circ J 2008 0.75